In instances where neonatal screening yields positive results (>70 ng/mL) but fewer than two CF-causing mutations are identified, recommendations entail undergoing a sweat test or nasal potential difference (NPD) assessment to ascertain CFTR dysfunction [25,26]. Here, CFTR is linked to cystic fibrosis.